A Holistic Approach to Study Non-Addictive Natural Products for Pain Management
Can you apply?
This grant is for research institutions and organizations conducting collaborative research on non-addictive natural products for chronic pain management. Eligible applicants typically include universities, research centers, nonprofits, and other research organizations capable of conducting rigorous mechanistic studies. The research must examine natural products through a holistic, multisystem approach that captures complex biological pathways. Studies may focus on botanicals, dietary supplements, or other naturally derived compounds used for pain relief.
Geographic scope is national. Projects should align with the NIH HEAL Initiative by promoting safe, non-addictive pain management strategies. Research should investigate how natural products influence pain across multiple organ systems, optimize dosing based on hormesis principles, and identify optimal intervention timing for pain and inflammation phases.
Key dates
- Apr 22, 2026 Applications open
- May 25, 2027 Application deadline in 346 days
- Apr 3, 2028 Award announced
- Apr 3, 2028 Project start
Program description
The National Center for Complementary and Integrative Health (NCCIH) intends to publish a Notice of Funding Opportunity (NOFO) to support collaborative interdisciplinary research that advances foundational understanding of non-addictive natural products for chronic pain management through a holistic, system-oriented approach. This initiative aligns with the NIH Helping to End Addiction Long-term (HEAL) Initiative by promoting safe, non-addictive, and prevention-oriented strategies for pain relief.
Chronic pain affects tens of millions of adults in the United States, contributing to disability, diminished quality of life, and significant healthcare costs. Despite widespread public use of natural products, such as botanicals, dietary supplements, and other naturally derived compounds for pain relief, scientific evidence has not kept pace with demand. Existing research often focuses on single molecular targets or isolated pathways, which fail to capture the complex, multisystem actions of these products.
The scope of natural products under this NOFO includes those commonly used by the public as well as those with emerging usage or therapeutic potential. Research is expected to take a holistic approach that examines how these products influence pain through coordinated biological pathways across the multiple organ systems, such as digestive, immune, vascular, musculoskeletal, lymphatic, metabolic/adipose tissues, and nervous system. Studies should also explore dose optimization based on the principle of hormesis, where low doses may elicit beneficial or adaptive effects while higher doses could be ineffective or harmful. In addition, investigators are encouraged to identify optimal intervention timing that aligns with the dynamic phases of pain and inflammation, thereby maximizing therapeutic outcomes and supporting physiological recovery.
This program emphasizes rigorous mechanistic studies that generate foundational insights to inform future translational research and guide the development of safe, evidence-based, non-addictive strategies for pain management.
Who can apply
Eligible applicants
How to apply
Application links
Key dates & requirements
Required documents
- SF-424 (R&R) Application for Federal Assistance
- Project Narrative/Research Strategy
- Specific Aims
- Research Design and Methods
- Biosketch for Key Personnel
- Budget Justification
- Facilities and Resources
- Literature Cited
- NIH Biographical Sketches
- Budget Form (R&R)
- Current and Pending Support Documentation
Program contact
- 👤 Division of Extramural Research (DER) Program Officer
- 📧 NCCIHDERFunding@nih.gov
- 📞 Please contact via e-mail.
Funding track record
No recent recipient data available for CFDA 93.473 in our database.
This can happen for newer programs, programs that use non-standard award types (loans, direct payments, fellowships), or those funded through sub-agencies under different codes.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.473). How funding has trended year over year.
| 2024 | $88,020,219 | |
| 2025 | $80,576,933 | |
| 2026 est. | $89,137,637 |
FAQ
Who can apply for this NCCIH research grant?
Eligible organizations include research universities, medical centers, nonprofits, government agencies, and other institutions capable of conducting federally funded research. Individual researchers must be affiliated with eligible institutions.
What types of natural products are in scope?
The grant covers botanicals, dietary supplements, and naturally derived compounds commonly used for pain relief, plus emerging products with therapeutic potential. Mechanistic research should examine multisystem effects, not just single molecular targets.
When is the deadline and can I submit early?
The deadline is May 25, 2027. Check NIH's electronic submission system for time-of-day details. Late submissions are typically not accepted.
What makes applications competitive?
Rigorous mechanistic design is essential. Competitive applications integrate multiple organ systems, address dose optimization through hormesis, and propose timing interventions aligned with pain/inflammation phases. Collaboration strengthens proposals.
What budget categories are typically allowed?
NIH grants typically allow personnel, equipment, supplies, travel, and indirect costs. Specific allowable costs depend on your institution's negotiated indirect rate and NIH guidelines.
💡 Tips for applicants
- Emphasize holistic, multisystem mechanistic research design over single-pathway studies. NIH prioritizes foundational insights that span digestive, immune, vascular, musculoskeletal, and nervous systems.
- Address dose optimization explicitly using hormesis principles. Show how low doses may provide adaptive benefits while higher doses are ineffective or harmful.
- Propose optimal intervention timing aligned with dynamic pain/inflammation phases. Demonstrate how timing maximizes therapeutic outcomes and supports physiological recovery.
- Build collaborative teams with complementary expertise across disciplines. The NCCIH values interdisciplinary approaches that address complex natural product mechanisms.
- Connect your research to the NIH HEAL Initiative goals of safe, non-addictive pain management. Show alignment with current national priorities for opioid alternatives.
⚠️ Common mistakes
Applications proposing reductionist research on single molecular targets typically fail; NCCIH expects multisystem, holistic mechanistic approaches. Inadequate exploration of dose-response relationships and hormesis principles weakens competitiveness. Vague or missing intervention timing strategies don't address NCCIH priorities for aligning treatment with pain/inflammation phases.
Similar grants
- OPEN Rural Community Health Integration2026 — New York State Department of Health
- OPEN FY26 Bureau of Land Management Rangeland Resource Management – Bureau wide — Bureau of Land Management
- OPEN FY26 Bureau of Land Management Cultural and Paleontological Resource Management – Bureau wide — Bureau of Land Management
- OPEN FY26 Bureau of Land Management Youth Conservation Corps – Bureau wide — Bureau of Land Management
- OPEN Infertility Training Center — Office of the Assistant Secretary for Health